Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials, also abroad
89 open Hypertrophic cardiomyopathy trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 21 |
| China | 19 |
| United Kingdom | 14 |
| Germany | 11 |
| France | 8 |
| All other countries |
The same trial often runs in several countries
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) has 1 site in Puerto Rico and runs in 9 countries. If a site near you is full, another one may still take people.
See A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) in all 9 countries